Investigating the role of microRNAs in Alzheimer's disease progression
Synaptosomal MicroRNAs, Synaptic Damage and Cognitive Decline in Alzheimer's Disease
This study is looking at tiny molecules in the brain that might play a role in how Alzheimer's disease develops, by comparing brain samples from people with Alzheimer's and those without, to see how these molecules change and what that might mean for brain health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Tech University Health Sciences Center at El Paso NIH-funded |
| Lab location | 1 site (El Paso, United States) |
| Project ID | NIH-10849918 on NIH RePORTER |
What this research studies
This research focuses on understanding how specific microRNAs found in synapses contribute to the progression of Alzheimer's disease. By analyzing brain samples from individuals with Alzheimer's and healthy controls, the study aims to identify which microRNAs are altered in Alzheimer's patients. The researchers will use advanced techniques to sequence and characterize these microRNAs, exploring their potential roles in synaptic damage and cognitive decline. This could lead to new insights into the mechanisms of Alzheimer's and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease and healthy individuals for comparison.
Not a fit: Patients with other forms of dementia or cognitive decline unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for diagnosing or treating Alzheimer's disease.
How similar studies have performed: While the role of microRNAs in other conditions has been studied, this specific investigation into synaptosomal microRNAs in Alzheimer's disease is relatively novel.
Where this research is happening
El Paso, United States
- Texas Tech University Health Sciences Center at El Paso — El Paso, United States (Active)
Researchers
- Principal investigator: Kumar, Subodh — Texas Tech University Health Sciences Center at El Paso
- Study coordinator: Kumar, Subodh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.